Shebli Atrash, M.D.
Levine Cancer Institute Before starting at the Levine Cancer Institute, [...]
Levine Cancer Institute Before starting at the Levine Cancer Institute, [...]
Keeping the Needs of the Patients at the Forefront of [...]
A Phase II, Open Label Study of Tucatinib Combined With [...]
Double Blind, Parallel Groups, Controlled, Randomized Phase II Trial to [...]
Neoadjuvant Regorafenib Plus Durvalumab (MEDI4736) in Patients with High-risk Hepatocellular [...]
A Randomized Phase II Study of Regorafenib Followed by Anti-EGFR [...]
PULSE: A Randomized, Phase II Open Label Study of Panitumumab [...]
COLOMATE: Colorectal Cancer Liquid Biopsy Screening Protocol for Molecularly Assigned [...]
Phase I Study of Irinotecan Liposome (nal-IRI), Fluorouracil and Rucaparib [...]
ACCRU News & Releases – February 2023 Academic and Community [...]